Abbott LaboratoriesvsTransMedics

ABT and TMDX stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$104.48

Value $182B

-0.22%
ABT's page

TMDX

TransMedics Group, Inc.

$96.43

Value $3.3B

+2.68%
TMDX's page

Abbott Laboratories (ABT) has a market value of $182B and TransMedics (TMDX) $3.3B. Over the last year, with dividends, ABT moved -17.7% and TMDX -15.0%. Dividend yield: ABT 2.41%, TMDX none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$182B

    TMDX$3.3B

    ABT is 55 times TMDX

  • Revenue, 12 months

    ABT$48.2B

    TMDX$728M

    ABT is 66 times TMDX

  • Net income, 12 months

    ABT$4.7B

    TMDX$144M

    ABT is 33 times TMDX

  • Operating margin

    ABT13.8%

    TMDX11.9%

    1.9 points apart

  • ROIC

    ABT6.3%

    TMDX7.2%

    0.9 points apart

  • P/E

    ABT38.6

    TMDX–

  • Dividend yield

    ABT2.4%

    TMDX0.0%

    2.4 points apart

  • 5-year return

    ABT-10.3%

    TMDX+304.0%

    314.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-10.3%

TMDX+304.0%

20040060020222023202420252026
Returns by period
PeriodABTWith dividendsTMDXWith dividends
1 year since November 17, 2025-17.7%Price -19.6%-15.0%Price -15.0%
3 years since November 17, 2023+11.8%+3.8% a yearPrice +5.0%+40.4%+12.0% a yearPrice +40.4%
5 years since November 17, 2021-10.3%-2.1% a yearPrice -18.8%+304.0%+32.2% a yearPrice +304.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesTMDXTransMedics

Valuation

ABTTMDX
Valuation
Price$104.48$96.43
Market value$182B$3.3B
Enterprise value (EV)$208B$3.7B
P/E38.6–
P/E, 5-year median33.7–
P/B3.66.0
EV/EBIT31.442.5
Free cash flow yield3.7%1.4%

Results and growth

ABTTMDX
Results and growth
Revenue, 12 months$48.2B$728M
Net income, 12 months$4.7B$144M
Free cash flow, 12 months$6.8B$45M
Earnings per share, 12 months$2.69$3.66
Revenue growth, year on year5.7%37.1%
Revenue growth a year, past+5.1%over 5 years+88.2%over 5 years
EPS growth a year, past+8.3%over 5 years–

Margins and returns on capital

ABTTMDX
Margins and returns on capital
Gross margin56.9%58.6%
Operating margin13.8%11.9%
Net margin9.8%19.9%
ROIC6.3%7.2%
ROE9.1%30.2%

Balance sheet

ABTTMDX
Balance sheet
Cash$4.3B$493M
Total debt$31.2B$867M
Net debt / EBITDA3.33.2
Interest cover6.7×3.5×

Dividends and buybacks

ABTTMDX
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%–
Shareholder yield2.9%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or TMDX

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or TransMedics?

By market value, Abbott Laboratories ($182B) is about 54.9 times TransMedics ($3.3B), at today's prices.

How did ABT and TMDX stock do over the last 5 years?

Since November 17, 2021, ABT's price moved -18.8% and TMDX's +304.0%. With dividends: ABT -10.3% (-2.1% a year), TMDX +304.0% (+32.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or TMDX?

The dividend yield at today's price is 2.41% for Abbott Laboratories and none for TransMedics. Over the last twelve months they paid $2.52 and – per share.

Which has the higher profit margins, Abbott Laboratories or TransMedics?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 19.9% for TransMedics, and the operating margin 13.8% and 11.9%. Revenue was $48.2B and $728M.

Which is the better investment, Abbott Laboratories or TransMedics?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.